Navigation Links
New study reveals long delays and variability are losing the UK research and jobs
Date:2/22/2010

Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.

The two year study focused on identifying the key social, organisational and managerial factors that influence clinical research projects in the UK. In the first study of its kind, the researchers carried out a national survey in which they interviewed key stakeholders and surveyed 247 clinical research projects about the challenges of managing clinical research. The study found that although patient recruitment was and remains a major challenge, retaining the project team was seen as critical to the ongoing success of clinical research and that this was becoming increasingly difficult. Additionally the research found that retaining the research team throughout the project was significantly hampered by aspects of the approval process; projects which had been approved by the regulatory bodies often then encountered difficulty in obtaining approval from the hospital Trusts and that there was huge variation in both the time and requirements needed to gain approval from these Trusts.

Professor Jacky Swan of Warwick Business School commented, "The problem is that to commercial organisations, time is very important and although many are committed to carrying out clinical research in this country, many are finding it easier to do this research abroad and that does have long term and significant implications for high quality research in the UK and also for the retention of skilled researchers." Additionally, Professor Swan stressed that the inconsistencies and lengthiness of the approvals processes has a detrimental effect on the completion rates of non- commercial organisations. "There are three elements of approval; regulation, ethics and research and development and although there has been improvement in regulation and there have been efforts to streamline the R&D process, these are not happening quickly enough to have a positive impact." she added.

"Far more policy attention is needed to address these problems; especially around the skills shortages that are emerging and aspects of the NHS culture which are making it very difficult to conduct the innovative, world-leading clinical research that the UK has always been known for." added Maxine Robertson, Professor of Innovation and Organisation at Queen Mary, University of London.


'/>"/>

Contact: Professor Jacky Swan
Jacky.Swan@wbs.ac.uk
44-024-765-24271
University of Warwick
Source:Eurekalert

Related medicine news :

1. More Bars Equals More Assaults, Study Finds
2. Webmarketing 123 Profiled in National Study of High Growth Professional Services Firms
3. CapSite Announces Release of the 2010 U.S. Ambulatory EHR Study
4. International study confirms doubling of childhood leukemia rates in southern Iraq
5. Dolphins could be ideal model to study human cervical cancer, UF veterinarians say
6. UCLA study reveals how genes interact with their environment to cause disease
7. Battlefield camaraderie yields long-term dividends for veterans, study finds
8. UAB-led study shows simple steps could reduce stillbirths by up to 1 million
9. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
10. Study supports alternative anti-seizure medication following acute brain injury
11. Scripps Health Begins Pioneering Study of Human Tumor Sequencing in Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Massachsetts (PRWEB) , ... May 26, 2017 , ... ... will gather at Boston CEO 2017 on May 30th and 31st at The ... networking forum for leading executives in the life sciences, offering exclusive access to ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community health data reveals ... located in the Midwest. With the average cost of healthcare rising and the U.S. ... both the quality and affordability of where they live. An annual 2017 report looked ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... After raising ... Antzy Top gadget will continue to be available at a discounted crowdfunding price on ... with stress wherever they are, I also wanted to bring a fidget toy to ...
(Date:5/26/2017)... ... 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in ... post on insurance options. If a Bay Area patient has to search for a ... money. Visiting an in-network provider for a second opinion can ensure a patient receives ...
(Date:5/26/2017)... ... ... Happened in the Garden of Eden”: retells the stories of three Bible figures in modern ... author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. Born ... At six, they moved to Dayton, Ohio, where Penny graduated high school. At sixteen, ...
Breaking Medicine News(10 mins):
(Date:5/6/2017)... N.Y. , May 5, 2017  Hill-Rom Holdings, ... will add approximately 100,000 square feet to its Welch ... September 2016 its commitment to bring more than 100 ... , where Welch Allyn has maintained a significant presence ... help accommodate these new positions, a large portion of ...
(Date:5/4/2017)... CAESAREA, Israel , May 4, 2017  DarioHealth ... with mobile health and big data solutions, today announced ... an A&D Company, and STI Technologies Limited to lower ... effective immediately. Through STI,s innoviCares card, which is available ... , DarioHealth customers will be eligible for additional ...
(Date:5/3/2017)... 3, 2017  Getinge, a leading global provider ... enhancement and cost efficiency within healthcare and life ... contemporary practice demonstrating that intra-aortic balloon counterpulsation (IABC) ... ill patients. The single-center, retrospective, observational study showed ... MEGA ® 50cc intra-aortic balloon (IAB) in ...
Breaking Medicine Technology: